nach oben

Erschienen in:

2020 | OriginalPaper | Buchkapitel

Human Pluripotent Stem Cells: Applications and Challenges for Regenerative Medicine and Disease Modeling

verfasst von : Cláudia C. Miranda, Tiago G. Fernandes, M. Margarida Diogo, Joaquim M. S. Cabral

Erschienen in: Current Applications of Pharmaceutical Biotechnology

Verlag: Springer International Publishing

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

In recent years, human pluripotent stem (hPS) cells have started to emerge as a potential tool with application in fields such as regenerative medicine, disease modeling, and drug screening. In particular, the ability to differentiate human-induced pluripotent stem (hiPS) cells into different cell types and to mimic structures and functions of a specific target organ, resourcing to organoid technology, has introduced novel model systems for disease recapitulation while offering a powerful tool to provide a faster and reproducible approach in the process of drug discovery. All these technologies are expected to improve the overall quality of life of the humankind. Here, we highlight the main applications of hiPS cells and the main challenges associated with the translation of hPS cell derivatives into clinical settings and other biomedical applications, such as the costs of the process and the ability to mimic the complexity of the in vivo systems. Moreover, we focus on the bioprocessing approaches that can be applied towards the production of high numbers of cells as well as their efficient differentiation into the final product and further purification.

Graphical Abstract

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Advances in Vaccines

Nächstes Kapitel Addressing the Manufacturing Challenges of Cell-Based Therapies

Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145–1147PubMedCrossRef

Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872PubMedCrossRef

Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME et al (2013) Cerebral organoids model human brain development and microcephaly. Nature 501(7467):373–379PubMedCrossRef

Miranda CC, Fernandes TG, Diogo MM, Cabral JMS (2018) Towards multi-organoid systems for drug screening applications. Bioengineering 5(3):E49PubMedCrossRef

Badenes SM, Fernandes TG, Cordeiro CS, Boucher S, Kuninger D, Vemuri MC et al (2016) Defined essential 8 medium and vitronectin efficiently support scalable xeno-free expansion of human induced pluripotent stem cells in stirred microcarrier culture systems. PLoS One 11(3):e0151264PubMedPubMedCentralCrossRef

Fonoudi H, Ansari H, Abbasalizadeh S, Larijani MR, Kiani S, Hashemizadeh S et al (2015) A universal and robust integrated platform for the scalable production of human cardiomyocytes from pluripotent stem cells. Stem Cells Transl Med 4(12):1482–1494PubMedPubMedCentralCrossRef

Miranda CC, Fernandes TG, Pinto SN, Prieto M, Diogo MM, Cabral JMS (2018) A scale out approach towards neural induction of human induced pluripotent stem cells for neurodevelopmental toxicity studies. Toxicol Lett 294:51–60PubMedCrossRef

Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292(5819):154–156PubMedCrossRef

Bongso A, Lee EH (2005) Stem cells: their definition, classification and sources. In: Bongso A, Lee EH (eds) Stem cells: from bench to bedside. World Scientific, Singapore, pp 1–13

10.

Campbell KH, McWhir J, Ritchie WA, Wilmut I (1996) Sheep cloned by nuclear transfer from a cultured cell line. Nature 380(6569):64–66PubMedCrossRef

11.

Cowan CA, Atienza J, Melton DA, Eggan K (2005) Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309(5739):1369–1373PubMedCrossRef

12.

Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676CrossRefPubMed

13.

Gurdon JB, Melton DA (2008) Nuclear reprogramming in cells. Science 322(5909):1811–1815PubMedCrossRef

14.

Patel M, Yang S (2010) Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev 6(3):367–380PubMedCentralCrossRef

15.

Pralong D, Trounson AO, Verma PJ (2006) Cell fusion for reprogramming pluripotency: toward elimination of the pluripotent genome. Stem Cell Rev 2(4):331–340PubMedCrossRef

16.

Zeuschner D, Mildner K, Zaehres H, Scholer HR (2010) Induced pluripotent stem cells at nanoscale. Stem Cells Dev 19(5):615–620PubMedCrossRef

17.

Okita K, Yamanaka S (2010) Induction of pluripotency by defined factors. Exp Cell Res 316(16):2565–2570PubMedCrossRef

18.

Draper JS, Pigott C, Thomson JA, Andrews PW (2002) Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat 200(Pt 3):249–258PubMedPubMedCentralCrossRef

19.

Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C et al (2009) Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5(1):111–123PubMedPubMedCentralCrossRef

20.

Gutierrez-Aranda I, Ramos-Mejia V, Bueno C, Munoz-Lopez M, Real PJ, Macia A et al (2010) Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. Stem Cells 28(9):1568–1570PubMedPubMedCentralCrossRef

21.

Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448(7151):313–317PubMedCrossRef

22.

Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II et al (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324(5928):797–801PubMedPubMedCentralCrossRef

23.

Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S et al (2011) A more efficient method to generate integration-free human iPS cells. Nat Methods 8(5):409–412PubMedCrossRef

24.

Schlaeger TM, Daheron L, Brickler TR, Entwisle S, Chan K, Cianci A et al (2015) A comparison of non-integrating reprogramming methods. Nat Biotechnol 33(1):58–63PubMedCrossRef

25.

Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F et al (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7(5):618–630PubMedPubMedCentralCrossRef

26.

Kelaini S, Cochrane A, Margariti A (2014) Direct reprogramming of adult cells: avoiding the pluripotent state. Stem Cells Cloning 7:19–29PubMedPubMedCentral

27.

Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG et al (2010) Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142(3):375–386PubMedPubMedCentralCrossRef

28.

Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M (2010) Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463(7284):1035–1041PubMedPubMedCentralCrossRef

29.

Margariti A, Winkler B, Karamariti E, Zampetaki A, Tsai TN, Baban D et al (2012) Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proc Natl Acad Sci U S A 109(34):13793–13798PubMedPubMedCentralCrossRef

30.

Noguchi H, Saitoh I, Tsugata T, Kataoka H, Watanabe M, Noguchi Y (2015) Induction of tissue-specific stem cells by reprogramming factors, and tissue-specific selection. Cell Death Differ 22(1):145–155PubMedCrossRef

31.

Bar-Nur O, Russ HA, Efrat S, Benvenisty N (2011) Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 9(1):17–23PubMedCrossRef

32.

Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P et al (2010) Epigenetic memory in induced pluripotent stem cells. Nature 467(7313):285–290PubMedPubMedCentralCrossRef

33.

Trounson A, McDonald C (2015) Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell 17(1):11–22PubMedCrossRef

34.

Keirstead H (2008) Challenges to the clinical viability of stem cell technology. In: Spinal cord injury – what are the barriers to cure? Bedford Center Workshop 29

35.

Morizane A, Kikuchi T, Hayashi T, Mizuma H, Takara S, Doi H et al (2017) MHC matching improves engraftment of iPSC-derived neurons in non-human primates. Nat Commun 8(1):385PubMedPubMedCentralCrossRef

36.

Shiba Y, Gomibuchi T, Seto T, Wada Y, Ichimura H, Tanaka Y et al (2016) Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature 538(7625):388–391PubMedCrossRef

37.

Kikuchi T, Morizane A, Doi D, Magotani H, Onoe H, Hayashi T et al (2017) Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model. Nature 548(7669):592–596PubMedCrossRef

38.

Piao J, Major T, Auyeung G, Policarpio E, Menon J, Droms L et al (2015) Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation. Cell Stem Cell 16(2):198–210PubMedPubMedCentralCrossRef

39.

Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S et al (2008) Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26(4):443–452PubMedCrossRef

40.

Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K et al (2005) Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25(19):4694–4705PubMedPubMedCentralCrossRef

41.

Kriks S, Shim JW, Piao J, Ganat YM, Wakeman DR, Xie Z et al (2011) Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease. Nature 480(7378):547–551PubMedPubMedCentralCrossRef

42.

Grealish S, Diguet E, Kirkeby A, Mattsson B, Heuer A, Bramoulle Y et al (2014) Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson’s disease. Cell Stem Cell 15(5):653–665PubMedPubMedCentralCrossRef

43.

Cyranoski D (2019) ‘Reprogrammed’ stem cells implanted into patient with Parkinson’s disease. https://www.nature.com/articles/d41586-018-07407-9

44.

Manley NC, Priest CA, Denham J, Wirth 3rd ED, Lebkowski JS (2017) Human embryonic stem cell-derived oligodendrocyte progenitor cells: preclinical efficacy and safety in cervical spinal cord injury. Stem Cells Transl Med 6(10):1917–1929PubMedPubMedCentralCrossRef

45.

Cyranoski D (2019) ‘Reprogrammed’ stem cells to treat spinal-cord injuries for the first time. https://www.nature.com/articles/d41586-019-00656-2

46.

Kobayashi Y, Okada Y, Itakura G, Iwai H, Nishimura S, Yasuda A et al (2012) Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. PLoS One 7(12):e52787PubMedPubMedCentralCrossRef

47.

Rezania A, Bruin JE, Riedel MJ, Mojibian M, Asadi A, Xu J et al (2012) Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 61(8):2016–2029PubMedPubMedCentralCrossRef

48.

Agulnick AD, Ambruzs DM, Moorman MA, Bhoumik A, Cesario RM, Payne JK et al (2015) Insulin-producing endocrine cells differentiated in vitro from human embryonic stem cells function in macroencapsulation devices in vivo. Stem Cells Transl Med 4(10):1214–1222PubMedPubMedCentralCrossRef

49.

Kawamura M, Miyagawa S, Miki K, Saito A, Fukushima S, Higuchi T et al (2012) Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126(11 Suppl 1):S29–S37PubMedCrossRef

50.

Xiong Q, Ye L, Zhang P, Lepley M, Tian J, Li J et al (2013) Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling. Circulation 127(9):997–1008PubMedPubMedCentralCrossRef

51.

Menasche P, Vanneaux V, Hagege A, Bel A, Cholley B, Parouchev A et al (2018) Transplantation of human embryonic stem cell-derived cardiovascular progenitors for severe ischemic left ventricular dysfunction. J Am Coll Cardiol 71(4):429–438PubMedCrossRef

52.

Trainor N, Pietak A, Smith T (2014) Rethinking clinical delivery of adult stem cell therapies. Nat Biotechnol 32(8):729–735PubMedCrossRef

53.

Badenes SM, Fernandes TG, Miranda CC, Pusch-Klein A, Haupt S, Rodrigues CAV et al (2017) Long-term expansion of human induced pluripotent stem cells in a microcarrier-based dynamic system. J Chem Technol Biotechnol 92(3):492–503CrossRef

54.

Rodrigues AL, Rodrigues CAV, Gomes AR, Vieira SF, Badenes SM, Diogo MM et al (2019) Dissolvable microcarriers allow scalable expansion and harvesting of human induced pluripotent stem cells under xeno-free conditions. Biotechnol J 14(4):e1800461PubMedCrossRef

55.

Badenes SM, Fernandes TG, Rodrigues CA, Diogo MM, Cabral JM (2015) Scalable expansion of human-induced pluripotent stem cells in xeno-free microcarriers. Methods Mol Biol 1283:23–29PubMedCrossRef

56.

Rodrigues CA, Silva TP, Nogueira DE, Fernandes TG, Hashimura Y, Wesselschmidt R et al (2018) Scalable culture of human induced pluripotent cells on microcarriers under xeno-free conditions using single-use vertical-wheel™ bioreactors. J Chem Technol Biotechnol 93(12):3597–3606CrossRef

57.

Kelm JM, Timmins NE, Brown CJ, Fussenegger M, Nielsen LK (2003) Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng 83(2):173–180PubMedCrossRef

58.

Burridge PW, Anderson D, Priddle H, Barbadillo Munoz MD, Chamberlain S, Allegrucci C et al (2007) Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells 25(4):929–938PubMedCrossRef

59.

Tung YC, Hsiao AY, Allen SG, Torisawa YS, Ho M, Takayama S (2011) High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst 136(3):473–478PubMedCrossRef

60.

Amit M, Laevsky I, Miropolsky Y, Shariki K, Peri M, Itskovitz-Eldor J (2011) Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat Protoc 6(5):572–579PubMedCrossRef

61.

Singh H, Mok P, Balakrishnan T, Rahmat SN, Zweigerdt R (2010) Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res 4(3):165–179PubMedCrossRef

62.

Otsuji TG, Bin J, Yoshimura A, Tomura M, Tateyama D, Minami I et al (2014) A 3D sphere culture system containing functional polymers for large-scale human pluripotent stem cell production. Stem Cell Reports 2(5):734–745PubMedPubMedCentralCrossRef

63.

Ungrin MD, Joshi C, Nica A, Bauwens C, Zandstra PW (2008) Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One 3(2):e1565PubMedPubMedCentralCrossRef

64.

Niebruegge S, Bauwens CL, Peerani R, Thavandiran N, Masse S, Sevaptisidis E et al (2009) Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol Bioeng 102(2):493–507PubMedCrossRef

65.

Jing D, Parikh A, Tzanakakis ES (2010) Cardiac cell generation from encapsulated embryonic stem cells in static and scalable culture systems. Cell Transplant 19(11):1397–1412PubMedCrossRef

66.

Carpenedo RL, Sargent CY, McDevitt TC (2007) Rotary suspension culture enhances the efficiency, yield, and homogeneity of embryoid body differentiation. Stem Cells 25(9):2224–2234PubMedCrossRef

67.

Cameron CM, Hu WS, Kaufman DS (2006) Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation. Biotechnol Bioeng 94(5):938–948PubMedCrossRef

68.

Zanghi JA, Renner WA, Bailey JE, Fussenegger M (2000) The growth factor inhibitor suramin reduces apoptosis and cell aggregation in protein-free CHO cell batch cultures. Biotechnol Prog 16(3):319–325PubMedCrossRef

69.

Lipsitz YY, Tonge PD, Zandstra PW (2018) Chemically controlled aggregation of pluripotent stem cells. Biotechnol Bioeng 115(8):2061–2066PubMedPubMedCentralCrossRef

70.

Bandeiras C, Cabral JMS, Gabbay RA, Finkelstein SN, Ferreira FC (2019) Bringing stem cell-based therapies for type 1 diabetes to the clinic: early insights from bioprocess economics and cost-effectiveness analysis. Biotechnol J 14(8):e1800563PubMedCrossRef

71.

Larijani MR, Seifinejad A, Pournasr B, Hajihoseini V, Hassani SN, Totonchi M et al (2011) Long-term maintenance of undifferentiated human embryonic and induced pluripotent stem cells in suspension. Stem Cells Dev 20(11):1911–1923PubMedCrossRef

72.

Abbasalizadeh S, Larijani MR, Samadian A, Baharvand H (2012) Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor. Tissue Eng Part C Methods 18(11):831–851PubMedCrossRef

73.

Amit M, Chebath J, Margulets V, Laevsky I, Miropolsky Y, Shariki K et al (2010) Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells. Stem Cell Rev 6(2):248–259CrossRef

74.

Steiner D, Khaner H, Cohen M, Even-Ram S, Gil Y, Itsykson P et al (2010) Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension. Nat Biotechnol 28(4):361–364PubMedCrossRef

75.

Wang Y, Chou BK, Dowey S, He C, Gerecht S, Cheng L (2013) Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions. Stem Cell Res 11(3):1103–1116PubMedPubMedCentralCrossRef

76.

Zweigerdt R, Olmer R, Singh H, Haverich A, Martin U (2011) Scalable expansion of human pluripotent stem cells in suspension culture. Nat Protoc 6(5):689–700PubMedCrossRef

77.

Chen VC, Couture SM, Ye J, Lin Z, Hua G, Huang HI et al (2012) Scalable GMP compliant suspension culture system for human ES cells. Stem Cell Res 8(3):388–402PubMedCrossRef

78.

Krawetz R, Taiani JT, Liu S, Meng G, Li X, Kallos MS et al (2010) Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. Tissue Eng Part C Methods 16(4):573–582PubMedCrossRef

79.

Hunt MM, Meng G, Rancourt DE, Gates ID, Kallos MS (2014) Factorial experimental design for the culture of human embryonic stem cells as aggregates in stirred suspension bioreactors reveals the potential for interaction effects between bioprocess parameters. Tissue Eng Part C Methods 20(1):76–89PubMedCrossRef

80.

Elanzew A, Sommer A, Pusch-Klein A, Brustle O, Haupt S (2015) A reproducible and versatile system for the dynamic expansion of human pluripotent stem cells in suspension. Biotechnol J 10(10):1589–1599PubMedCrossRef

81.

Greuel S, Hanci G, Bohme M, Miki T, Schubert F, Sittinger M et al (2019) Effect of inoculum density on human-induced pluripotent stem cell expansion in 3D bioreactors. Cell Prolif 52(4):e12604PubMedPubMedCentralCrossRef

82.

Olmer R, Lange A, Selzer S, Kasper C, Haverich A, Martin U et al (2012) Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. Tissue Eng Part C Methods 18(10):772–784PubMedPubMedCentralCrossRef

83.

Kropp C, Kempf H, Halloin C, Robles-Diaz D, Franke A, Scheper T et al (2016) Impact of feeding strategies on the scalable expansion of human pluripotent stem cells in single-use stirred tank bioreactors. Stem Cells Transl Med 5(10):1289–1301PubMedPubMedCentralCrossRef

84.

Manstein F, Halloin C, Zweigerdt R (2019) Human pluripotent stem cell expansion in stirred tank bioreactors. Methods Mol Biol 1994:79–91PubMedCrossRef

85.

Kempf H, Kropp C, Olmer R, Martin U, Zweigerdt R (2015) Cardiac differentiation of human pluripotent stem cells in scalable suspension culture. Nat Protoc 10(9):1345–1361PubMedCrossRef

86.

Kempf H, Olmer R, Kropp C, Ruckert M, Jara-Avaca M, Robles-Diaz D et al (2014) Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture. Stem Cell Reports 3(6):1132–1146PubMedPubMedCentralCrossRef

87.

Olmer R, Haase A, Merkert S, Cui W, Palecek J, Ran C et al (2010) Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res 5(1):51–64PubMedCrossRef

88.

Chen VC, Ye J, Shukla P, Hua G, Chen D, Lin Z et al (2015) Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells. Stem Cell Res 15(2):365–375PubMedPubMedCentralCrossRef

89.

Zweigerdt R (2009) Large scale production of stem cells and their derivatives. Adv Biochem Eng Biotechnol 114:201–235PubMed

90.

Miranda CC, Fernandes TG, Pascoal JF, Haupt S, Brustle O, Cabral JM et al (2015) Spatial and temporal control of cell aggregation efficiently directs human pluripotent stem cells towards neural commitment. Biotechnol J 10(10):1612–1624PubMedCrossRef

91.

Miranda CC, Fernandes TG, Diogo MM, Cabral JM (2016) Scaling up a chemically-defined aggregate-based suspension culture system for neural commitment of human pluripotent stem cells. Biotechnol J 11(12):1628–1638PubMedCrossRef

92.

Branco MA, Cotovio JP, Rodrigues CAV, Vaz SH, Fernandes TG, Moreira LM et al (2019) Transcriptomic analysis of 3D cardiac differentiation of human induced pluripotent stem cells reveals faster cardiomyocyte maturation compared to 2D culture. Sci Rep 9(1):9229PubMedPubMedCentralCrossRef

93.

Lian X, Hsiao C, Wilson G, Zhu K, Hazeltine LB, Azarin SM et al (2012) Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A 109(27):E1848–E1857PubMedPubMedCentralCrossRef

94.

Schulz TC, Young HY, Agulnick AD, Babin MJ, Baetge EE, Bang AG et al (2012) A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS One 7(5):e37004PubMedPubMedCentralCrossRef

95.

Yabe SG, Fukuda S, Nishida J, Takeda F, Nashiro K, Okochi H (2019) Induction of functional islet-like cells from human iPS cells by suspension culture. Regen Ther 10:69–76PubMedPubMedCentralCrossRef

96.

Diogo MM, da Silva CL, Cabral JM (2012) Separation technologies for stem cell bioprocessing. Biotechnol Bioeng 109(11):2699–2709PubMedCrossRef

97.

Rodrigues GM, Rodrigues CA, Fernandes TG, Diogo MM, Cabral JM (2015) Clinical-scale purification of pluripotent stem cell derivatives for cell-based therapies. Biotechnol J 10(8):1103–1114PubMedCrossRef

98.

Fukuda H, Takahashi J, Watanabe K, Hayashi H, Morizane A, Koyanagi M et al (2006) Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation. Stem Cells 24(3):763–771PubMedCrossRef

99.

Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B et al (2010) A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 120(4):1125–1139PubMedPubMedCentralCrossRef

100.

Menasche P, Vanneaux V, Fabreguettes JR, Bel A, Tosca L, Garcia S et al (2015) Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience. Eur Heart J 36(12):743–750PubMedCrossRef

101.

Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM et al (2012) Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379(9817):713–720PubMedCrossRef

102.

Lu B, Malcuit C, Wang S, Girman S, Francis P, Lemieux L et al (2009) Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 27(9):2126–2135PubMedCrossRef

103.

Priest CA, Manley NC, Denham J, Wirth 3rd ED, Lebkowski JS (2015) Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury. Regen Med 10(8):939–958PubMedCrossRef

104.

Hattori F, Chen H, Yamashita H, Tohyama S, Satoh YS, Yuasa S et al (2010) Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods 7(1):61–66PubMedCrossRef

105.

Tohyama S, Hattori F, Sano M, Hishiki T, Nagahata Y, Matsuura T et al (2013) Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12(1):127–137PubMedCrossRef

106.

Lin B, Lin X, Stachel M, Wang E, Luo Y, Lader J et al (2017) Culture in glucose-depleted medium supplemented with fatty acid and 3,3′,5-triiodo-l-thyronine facilitates purification and maturation of human pluripotent stem cell-derived cardiomyocytes. Front Endocrinol 8:253CrossRef

107.

Nagashima T, Shimizu K, Matsumoto R, Honda H (2018) Selective elimination of human induced pluripotent stem cells using medium with high concentration of L-alanine. Sci Rep 8(1):12427PubMedPubMedCentralCrossRef

108.

Lancaster MA, Knoblich JA (2014) Organogenesis in a dish: modeling development and disease using organoid technologies. Science 345(6194):1247125PubMedCrossRef

109.

Peerani R, Rao BM, Bauwens C, Yin T, Wood GA, Nagy A et al (2007) Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J 26(22):4744–4755PubMedPubMedCentralCrossRef

110.

Arora N, Imran Alsous J, Guggenheim JW, Mak M, Munera J, Wells JM et al (2017) A process engineering approach to increase organoid yield. Development 144(6):1128–1136PubMedPubMedCentralCrossRef

111.

Kinney MA, Sargent CY, McDevitt TC (2011) The multiparametric effects of hydrodynamic environments on stem cell culture. Tissue Eng Part B Rev 17(4):249–262PubMedPubMedCentralCrossRef

112.

Garcez PP, Loiola EC, Madeiro da Costa R, Higa LM, Trindade P, Delvecchio R et al (2016) Zika virus impairs growth in human neurospheres and brain organoids. Science 352(6287):816–818PubMedCrossRef

113.

Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T et al (2013) Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499(7459):481–484PubMedCrossRef

114.

Sachs N, Tsukamoto Y, Kujala P, Peters PJ, Clevers H (2017) Intestinal epithelial organoids fuse to form self-organizing tubes in floating collagen gels. Development 144(6):1107–1112PubMedCrossRef

115.

Lu YC, Fu DJ, An D, Chiu A, Schwartz R, Nikitin AY et al (2017) Scalable production and cryostorage of organoids using core-shell decoupled hydrogel capsules. Adv Biosyst 1(12):1700165PubMedPubMedCentralCrossRef

116.

Dye BR, Hill DR, Ferguson MA, Tsai YH, Nagy MS, Dyal R et al (2015) In vitro generation of human pluripotent stem cell derived lung organoids. eLife 4:05098CrossRef

117.

Finkbeiner SR, Hill DR, Altheim CH, Dedhia PH, Taylor MJ, Tsai YH et al (2015) Transcriptome-wide analysis reveals hallmarks of human intestine development and maturation in vitro and in vivo. Stem Cell Reports 4(6):1140–1155PubMedCentralCrossRef

118.

Ronaldson-Bouchard K, Ma SP, Yeager K, Chen T, Song L, Sirabella D et al (2018) Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature 556(7700):239–243PubMedPubMedCentralCrossRef

119.

Halloin C, Coffee M, Manstein F, Zweigerdt R (1994) Production of cardiomyocytes from human pluripotent stem cells by bioreactor technologies. Methods Mol Biol 2019:55–70

120.

Marchetto MC, Carromeu C, Acab A, Yu D, Yeo GW, Mu Y et al (2010) A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143(4):527–539PubMedPubMedCentralCrossRef

121.

Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flugel L et al (2010) Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 363(15):1397–1409PubMedCrossRef

122.

Crespo M, Vilar E, Tsai SY, Chang K, Amin S, Srinivasan T et al (2017) Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing. Nat Med 23(7):878–884PubMedPubMedCentralCrossRef

123.

Pasinelli P, Brown RH (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7(9):710–723PubMedCrossRef

124.

Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W et al (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321(5893):1218–1221PubMedCrossRef

125.

Osaki T, Uzel SGM, Kamm RD (2018) Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons. Sci Adv 4(10):eaat5847PubMedPubMedCentralCrossRef

126.

Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG et al (2009) Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136(5):964–977PubMedPubMedCentralCrossRef

127.

Crawford TO, Pardo CA (1996) The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 3(2):97–110PubMedCrossRef

128.

Ebert AD, Yu J, Rose Jr FF, Mattis VB, Lorson CL, Thomson JA et al (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457(7227):277–280PubMedCrossRef

129.

Fernandes TG, Duarte ST, Ghazvini M, Gaspar C, Santos DC, Porteira AR et al (2015) Neural commitment of human pluripotent stem cells under defined conditions recapitulates neural development and generates patient-specific neural cells. Biotechnol J 10(10):1578–1588PubMedCrossRef

130.

Slaugenhaupt SA, Blumenfeld A, Gill SP, Leyne M, Mull J, Cuajungco MP et al (2001) Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 68(3):598–605PubMedPubMedCentralCrossRef

131.

Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, Fasano CA et al (2009) Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461(7262):402–406PubMedPubMedCentralCrossRef

132.

Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60(12):1187–1192PubMedCrossRef

133.

Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S et al (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature 473(7346):221–225PubMedPubMedCentralCrossRef

134.

Hershberger RE, Hedges DJ, Morales A (2013) Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol 10(9):531–547PubMedCrossRef

135.

Hinson JT, Chopra A, Nafissi N, Polacheck WJ, Benson CC, Swist S et al (2015) HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science 349(6251):982–986PubMedPubMedCentralCrossRef

136.

Mendell JR, Shilling C, Leslie ND, Flanigan KM, al-Dahhak R, Gastier-Foster J et al (2012) Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol 71(3):304–313PubMedCrossRef

137.

Lin B, Li Y, Han L, Kaplan AD, Ao Y, Kalra S et al (2015) Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy. Dis Model Mech 8(5):457–466PubMedPubMedCentralCrossRef

138.

Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA (2001) In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19(12):1129–1133PubMedCrossRef

139.

Muguruma K, Nishiyama A, Kawakami H, Hashimoto K, Sasai Y (2015) Self-organization of polarized cerebellar tissue in 3D culture of human pluripotent stem cells. Cell Rep 10(4):537–550PubMedCrossRef

140.

Eiraku M, Takata N, Ishibashi H, Kawada M, Sakakura E, Okuda S et al (2011) Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 472(7341):51–56PubMedCrossRef

141.

Bagley JA, Reumann D, Bian S, Levi-Strauss J, Knoblich JA (2017) Fused cerebral organoids model interactions between brain regions. Nat Methods 14(7):743–751PubMedPubMedCentralCrossRef

142.

Bershteyn M, Nowakowski TJ, Pollen AA, Di Lullo E, Nene A, Wynshaw-Boris A et al (2017) Human iPSC-derived cerebral organoids model cellular features of lissencephaly and reveal prolonged mitosis of outer radial glia. Cell Stem Cell 20(4):435–49 e4PubMedPubMedCentralCrossRef

143.

Mariani J, Coppola G, Zhang P, Abyzov A, Provini L, Tomasini L et al (2015) FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders. Cell 162(2):375–390PubMedPubMedCentralCrossRef

144.

Sampaziotis F, de Brito MC, Madrigal P, Bertero A, Saeb-Parsy K, Soares FAC et al (2015) Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation. Nat Biotechnol 33(8):845–852PubMedPubMedCentralCrossRef

145.

McCauley KB, Hawkins F, Serra M, Thomas DC, Jacob A, Kotton DN (2017) Efficient derivation of functional human airway epithelium from pluripotent stem cells via temporal regulation of wnt signaling. Cell Stem Cell 20(6):844–857.e6PubMedPubMedCentralCrossRef

146.

Workman MJ, Mahe MM, Trisno S, Poling HM, Watson CL, Sundaram N et al (2017) Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system. Nat Med 23(1):49–59PubMedCrossRef

147.

Baio J, Wiggins L, Christensen DL, Maenner MJ, Daniels J, Warren Z et al (2018) Prevalence of autism spectrum disorder among children aged 8 years – autism and developmental disabilities monitoring network, 11 sites, United States, 2014. Morb Mortal Wkly Rep Surveill Summ 67(6):1–23

148.

Nagamani SC, Zhang F, Shchelochkov OA, Bi W, Ou Z, Scaglia F et al (2009) Microdeletions including YWHAE in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment. J Med Genet 46(12):825–833PubMedCrossRef

149.

Furness JB (2012) The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol 9(5):286–294PubMedCrossRef

150.

McKeown SJ, Stamp L, Hao MM, Young HM (2013) Hirschsprung disease: a developmental disorder of the enteric nervous system. Wiley Interdiscip Rev Dev Biol 2(1):113–129PubMedCrossRef

151.

Wimmer RA, Leopoldi A, Aichinger M, Wick N, Hantusch B, Novatchkova M et al (2019) Human blood vessel organoids as a model of diabetic vasculopathy. Nature 565(7740):505–510PubMedCrossRefPubMedCentral

152.

Sander JD, Joung JK (2014) CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 32(4):347–355PubMedPubMedCentralCrossRef

153.

Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE et al (2013) RNA-guided human genome engineering via Cas9. Science 339(6121):823–826PubMedPubMedCentralCrossRef

154.

Xu X, Tay Y, Sim B, Yoon SI, Huang Y, Ooi J et al (2017) Reversal of phenotypic abnormalities by CRISPR/Cas9-mediated gene correction in Huntington disease patient-derived induced pluripotent stem cells. Stem Cell Reports 8(3):619–633PubMedPubMedCentralCrossRef

155.

Wang L, Yi F, Fu L, Yang J, Wang S, Wang Z et al (2017) CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs. Protein Cell 8(5):365–378PubMedPubMedCentralCrossRef

156.

Poon A, Schmid B, Pires C, Nielsen TT, Hjermind LE, Nielsen JE et al (2016) Generation of a gene-corrected isogenic control hiPSC line derived from a familial Alzheimer’s disease patient carrying a L150P mutation in presenilin 1. Stem Cell Res 17(3):466–469PubMedCrossRef

157.

Yang Y, Zhang X, Yi L, Hou Z, Chen J, Kou X et al (2016) Naive induced pluripotent stem cells generated from beta-thalassemia fibroblasts allow efficient gene correction with CRISPR/Cas9. Stem Cells Transl Med 5(1):8–19PubMedCrossRef

158.

Ye L, Wang J, Beyer AI, Teque F, Cradick TJ, Qi Z et al (2014) Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Delta32 mutation confers resistance to HIV infection. Proc Natl Acad Sci U S A 111(26):9591–9596PubMedPubMedCentralCrossRef

159.

Kosicki M, Tomberg K, Bradley A (2018) Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nat Biotechnol 36(8):765–771PubMedPubMedCentralCrossRef

160.

Zhou T, Tan L, Cederquist GY, Fan Y, Hartley BJ, Mukherjee S et al (2017) High-content screening in hPSC-neural progenitors identifies drug candidates that inhibit Zika virus infection in fetal-like organoids and adult brain. Cell Stem Cell 21(2):274–283.e5PubMedPubMedCentralCrossRef

161.

Chao MP, Gentles AJ, Chatterjee S, Lan F, Reinisch A, Corces MR et al (2017) Human AML-iPSCs reacquire leukemic properties after differentiation and model clonal variation of disease. Cell Stem Cell 20(3):329–44 e7PubMedPubMedCentralCrossRef

162.

Akazawa T, Yoshida S, Ohnishi S, Kanazu T, Kawai M, Takahashi K (2018) Application of intestinal epithelial cells differentiated from human induced pluripotent stem cells for studies of prodrug hydrolysis and drug absorption in the small intestine. Drug Metab Dispos 46(11):1497–1506PubMedCrossRef

163.

Skardal A, Murphy SV, Devarasetty M, Mead I, Kang HW, Seol YJ et al (2017) Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform. Sci Rep 7(1):8837PubMedPubMedCentralCrossRef

164.

Gomez-Lechon MJ, Donato MT, Castell JV, Jover R (2003) Human hepatocytes as a tool for studying toxicity and drug metabolism. Curr Drug Metab 4(4):292–312PubMedCrossRef

165.

Vcelar S, Jadhav V, Melcher M, Auer N, Hrdina A, Sagmeister R et al (2018) Karyotype variation of CHO host cell lines over time in culture characterized by chromosome counting and chromosome painting. Biotechnol Bioeng 115(1):165–173PubMedCrossRef

166.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O (2016) Engineering stem cell organoids. Cell Stem Cell 18(1):25–38PubMedPubMedCentralCrossRef

167.

Takasato M, Er PX, Chiu HS, Maier B, Baillie GJ, Ferguson C et al (2015) Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526(7574):564–568PubMedCrossRef

Titel: Human Pluripotent Stem Cells: Applications and Challenges for Regenerative Medicine and Disease Modeling
verfasst von: Cláudia C. Miranda
Tiago G. Fernandes
M. Margarida Diogo
Joaquim M. S. Cabral
Verlag: Springer International Publishing
Buch: Current Applications of Pharmaceutical Biotechnology
Print ISBN: 978-3-030-40463-5

Electronic ISBN: 978-3-030-40464-2

Copyright-Jahr: 2020
DOI: https://doi.org/10.1007/10_2019_117

Premium Partner

Marktübersichten

Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.

Zur Marktübersicht